12 results
8-K
EX-3.3
IMNM
Immunome Inc
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
8-K
EX-3.4
IMNM
Immunome Inc
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
8-K
EX-3.2
IMNM
Immunome Inc
4 Oct 23
Immunome and Morphimmune Announce Successful Completion of Merger with $125 Million PIPE to Develop Novel Targeted Cancer Therapies
6:56am
8-K
EX-3.2
IMNM
Immunome Inc
6 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
8-K
EX-3.1
IMNM
Immunome Inc
6 Oct 20
Amendments to Articles of Incorporation or Bylaws
4:05pm
S-1/A
EX-3.1
6galyja3
24 Sep 20
IPO registration (amended)
7:18am
S-1
EX-3.2
psf6w67cw6m3o2o
9 Sep 20
IPO registration
4:19pm
S-1
EX-3.4
75pvd54wcjwuju4t5il
9 Sep 20
IPO registration
4:19pm
S-1
EX-3.3
k6sa2jq 9t
9 Sep 20
IPO registration
4:19pm
S-1
EX-3.1
t1ltyajg lad
9 Sep 20
IPO registration
4:19pm
DRS
EX-3.2
u0w493ea ie
12 Aug 20
Draft registration statement
12:00am
DRS
EX-3.1
m8blfey1v1u8gon
12 Aug 20
Draft registration statement
12:00am
- Prev
- 1
- Next